Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-015689

Odonate Therapeutics, Inc. · ODT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael S Hearne
Officer — Chief Financial Officer
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 4:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 28, 2019A39$14.01A874D
Common StockF2holding———12,946,038IBy LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F3$16.48Feb 28, 2019A39A—Feb 28, 2029Common Stock3939D

Explanation of responses